Table 1.
Patient demographics.
| A | B | C | P-value | |
|---|---|---|---|---|
| No patients (n=) | 26 | 25 | 25 | |
| Age (years) | 59 | 59 | 63 | 0.631 ns ϕ |
| Gender (F:M) | 8:18 | 9:16 | 12:13 | 0.443 ns ϕ |
| Height (m) | 1.74 | 1.71 | 1.70 | 0.349 ns ϕ |
| Weight (kg) | 92.4 | 89.4 | 84.7 | 0.516 ns ϕ |
| BMI | 30.4 | 30.3 | 29.15 | 0.753 ns ϕ |
| Co-morbidities | ||||
| DVT (n=) | 12 | 9 | 14 | 0.362 ns ϕ |
| DM | 5 | 2 | 2 | 0.365 ns ϕ |
| HT | 2 | 5 | 5 | 0.384 ns ϕ |
| IHD | 4 | 2 | 4 | 0.656 ns ϕ |
| Heart failure | 2 | 1 | 1 | 0.799 ns ϕ |
| History malignancy | 2 | 3 | 2 | 0.872 ns ϕ |
| Obese (BMI≥30) | 14 | 11 | 8 | 0.348 ns ϕ |
| CEAPmedian (Clinical classification) | 4 | 4 | 4 | 0.203 ns ϕ |
| VCSSmedian | 6 | 6 | 7 | 0.414 ns γ |
BMI body mass index, CEAP Clinical Aetiological Anatomical Pathological criteria, VCSS Venous Clinical Severity Score, ns – non-significant, ϕ One Way ANOVA, γ Kruskal-Wallis test.
Statistical significance defined as P<0.05.